The swift and successful development of COVID-19 vaccines is a feat of modern medicine ― not only raising hope for an eventual end to the coronavirus pandemic, but spotlighting the groundbreaking innovations that are transforming medicine today. These advances extend across a variety of diseases and hold enormous promise for patients, investors and global society.

Equity portfolio manager Cheryl Frank and biotechnology analyst Laura Nelson Carney provided a ground-level view of this emerging medical era.

Among the topics they discussed:
 

• The latest developments in the fight against COVID-19
• China’s rise as a global force in drug discovery
• Medical innovation in the coming decade
• What it all could mean for health care investing